[The cancerogenicity of antineoplastic agents].
D000368:Aged; D000477:Alkylating Agents / Q000009:adverse effects; D000818:Animals; D000963:Antimetabolites / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002066:Busulfan / Q000009:adverse effects; D005260:Female; D006801:Humans; D008875:Middle Aged; D009153:Mutagens; D009369:Neoplasms / Q000139:chemically induced* / Q000601:surgery; D011182:Postoperative Care; D011183:Postoperative Complications; D051381:Rats; D014228:Triaziquone / Q000009:adverse effects
D000477:Alkylating Agents; D000963:Antimetabolites; D000970:Antineoplastic Agents; D009153:Mutagens; D014228:Triaziquone; D002066:Busulfan
Zur Frage der Kanzerogenität von Zytostatika.